Can pregabalin (lyrica) withdrawal cause seizures in an 80-year-old male?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pregabalin Withdrawal Can Cause Seizures in Elderly Patients

Yes, abrupt discontinuation of pregabalin can cause seizures in an 80-year-old male, and pregabalin should be tapered gradually rather than stopped suddenly to prevent withdrawal symptoms including seizures. 1

Mechanism and Risk Factors

Pregabalin, like other gabapentinoids, works on the central nervous system through binding to voltage-gated calcium channels, affecting neurotransmitter release. When discontinued abruptly, this can lead to:

  • Neuronal hyperexcitability
  • Disruption of GABA-mediated inhibition
  • Increased seizure risk, especially in elderly patients

Elderly patients (80 years old) are at particularly high risk due to:

  • Age-related changes in drug metabolism
  • Potential comorbidities affecting drug clearance
  • Increased neuronal vulnerability

Evidence of Seizure Risk

The FDA drug label for pregabalin specifically warns that abrupt or rapid discontinuation can increase seizure frequency in patients with seizure disorders 1. Following abrupt discontinuation, patients may experience:

  • Insomnia
  • Nausea
  • Headache
  • Anxiety
  • Hyperhidrosis
  • Diarrhea
  • Seizures

Case reports document serious withdrawal symptoms even in patients taking regular prescribed doses of pregabalin 2. A particularly relevant case involved an 80-year-old man who developed multifocal negative myoclonus and confusion after starting pregabalin, demonstrating the neurological vulnerability in this age group 3.

Another case report documented status epilepticus following abrupt discontinuation of gabapentin (a similar medication to pregabalin) in a patient with no previous seizure history 4, highlighting the potential severity of gabapentinoid withdrawal.

Proper Discontinuation Protocol

To prevent withdrawal symptoms including seizures:

  1. Taper pregabalin gradually over a minimum of 1 week rather than discontinuing abruptly 1
  2. For elderly patients or those on long-term therapy, a more conservative approach is recommended:
    • Reduce dose by 25% weekly over 4-6 weeks 5
    • Monitor closely for withdrawal symptoms
    • Slow the taper if significant withdrawal symptoms emerge

Monitoring During Tapering

During the tapering process, monitor for:

  • Early withdrawal symptoms: anxiety, insomnia, nausea
  • Neurological symptoms: tremors, myoclonus
  • Signs of seizure activity
  • Autonomic symptoms: sweating, tachycardia, hypertension

Management of Withdrawal

If withdrawal symptoms occur during tapering:

  • Temporarily return to the previous stable dose
  • Resume tapering with smaller incremental reductions
  • Consider adjunctive medications if needed:
    • Benzodiazepines may be used temporarily for severe withdrawal symptoms 5
    • Anticonvulsants may be considered for seizure prophylaxis in high-risk patients

Conclusion

Elderly patients are particularly vulnerable to pregabalin withdrawal effects, including seizures. The risk is significant enough that the FDA specifically warns against abrupt discontinuation 1. Always taper pregabalin gradually in elderly patients, with even more caution than in younger adults, to prevent potentially life-threatening withdrawal seizures.

References

Research

Negative myoclonus associated with pregabalin.

Yeungnam University journal of medicine, 2018

Research

Gabapentin withdrawal presenting as status epilepticus.

Journal of toxicology. Clinical toxicology, 2002

Guideline

Substance Withdrawal Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.